Center for Molecular and Vascular Biology (CMVB), Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium; Biomedical MRI unit, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.
Biomedical MRI unit, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.
Neurobiol Dis. 2024 Nov;202:106709. doi: 10.1016/j.nbd.2024.106709. Epub 2024 Oct 19.
Endothelial dysfunction is considered a key element in the early pathogenesis of neurodegenerative disorders. Dysfunction of the cerebral endothelial cells can result in dysregulation of cerebral perfusion and disruption of the Blood Brain Barrier (BBB), leading to brain damage, neurodegeneration and cognitive decline. It has been shown that the presence of modifiable risk factors exacerbates endothelial dysfunction. This study primarily aimed to identify which among various perfusion MRI methodologies could be effectively utilized to non-invasively identify early pathological alterations as a result of endothelial dysfunction. We compared these perfusion MRI measurements to invasive immunohistochemistry to detect early pathological alterations in the cerebral vasculature of a rat model of multiple cardiovascular co-morbidities (the ZSF1 Obese rat) at several stages of the cerebrovascular pathology. We observed cerebral hyperperfusion, expressed by increased Cerebral Blood Flow (CBF) and increased BBB permeability in the ZSF1 Obese rats, at an early stage of disease development. The increase in CBF observed with Arterial Spin Labeling (ASL) was lost during later stages of disease progression. These findings are in line with recent clinical findings in early stages of Alzheimer's disease (AD), that also show early increases in CBF.
内皮功能障碍被认为是神经退行性疾病早期发病机制中的一个关键因素。脑内皮细胞功能障碍可导致脑灌注失调和血脑屏障 (BBB) 破坏,从而导致脑损伤、神经退行性变和认知能力下降。已有研究表明,可改变的风险因素会加重内皮功能障碍。本研究主要目的是确定各种灌注 MRI 方法中哪一种可以有效地用于无创识别内皮功能障碍导致的早期病理改变。我们将这些灌注 MRI 测量值与侵袭性免疫组织化学进行了比较,以检测多种心血管合并症(ZSF1 肥胖大鼠)大鼠模型脑血管病各个阶段的脑血管早期病理改变。我们观察到 ZSF1 肥胖大鼠在疾病发展的早期阶段出现脑高灌注,表现为脑血流 (CBF) 增加和 BBB 通透性增加。动脉自旋标记 (ASL) 观察到的 CBF 增加在疾病进展的后期阶段消失。这些发现与阿尔茨海默病 (AD) 早期阶段的最近临床发现一致,也显示 CBF 早期增加。